Page 83 - 2020Taiwan Food and Drug Administration Annual Report
P. 83

the testing institution, management of certification and testing institutions, the procedures
                     of entrusted certification operations, management of entrusted certification agencies, and
                     DQQH[HV  ZKLFK ZHUH RI¿FLDOO\ DQQRXQFHG RQ $XJXVW         DV WKH EDVLV RI FRQGXFWLQJ UHODWHG
                     FHUWL¿FDWLRQ RI WHVWLQJ LQVWLWXWLRQV


                     $
                     $FKLHYHPHQWV DQG %HQH¿WVFKLHYHPHQWV DQG %HQH¿WV

                         By continuously improving the inspection and analysis capabilities in the laboratory, we
                     introduced new analytical technologies to establish test methods and comprehensively improve
                     the analytical techniques and standard to ensure the quality and safety of products. TFDA
                     aggressively facilitated the international interaction of analytical technology, to strengthen
                     the inspection and analysis capabilities to meet the international standards through interaction
                     and sharing of the global progress in analytical technology as well as challenges in the future.
                     In accordance with the “Regulations Governing Accreditation and Outsourced Accreditation
                     Management of Cosmetic Testing Institutions,” a total of 15 cosmetic inspection institutions
                     have been certified, with 51 certification inspection items, to strengthen the supervision and

                     management of inspection institutions and ensure the inspection quality.




                     4FDUJPO   c-BCPSBUPSZ .BOBHFNFOU PG 1SFDJTJPO .FEJDJOF

                                     .PMFDVMBS 5FTUJOH

                                                 y
                     Introduction of the Polic
                     Introduction of the Policy
                         Different from conventional medicine, the precision medicine not only refers to
                     conventional medical information but also information such as the genetic composition,

                     EDFNJURXQG HQYLURQPHQW  DQG OLIHVW\OH RI DQ LQGLYLGXDO RU VSHFL¿F JURXS  ,W LV DEOH WR VWLSXODWH
                     more accurate and personalized plans for disease prevention, diagnosis, and treatment through
                     the comparison and analysis of the human genetic database. In view of the prosperous
                     development of relevant service in medical, TFDA announced the “Guidance on Laboratory
                     Developed Tests and Services (LDTS) for precision medicine molecular testing” and conducted
                     the listing management of precision medicine molecular testing laboratory to improve the testing
                     quality.



                                              gy
                     Implementation Strate
                     Implementation Strategy
                         To conduct the registration management of precision medicine molecular testing laboratory,
                     TFDA invited experts with expertise in pathology, medical inspection and molecular testing to



                                                                                                           81
   78   79   80   81   82   83   84   85   86   87   88